GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 203 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $40,367,000 | -60.9% | 1,152,686 | -54.5% | 0.04% | -64.5% |
Q1 2021 | $103,292,000 | -5.3% | 2,534,773 | +0.7% | 0.12% | -12.7% |
Q4 2020 | $109,067,000 | +63.9% | 2,518,288 | +108.7% | 0.14% | +36.5% |
Q3 2020 | $66,537,000 | +12.0% | 1,206,689 | +28.2% | 0.10% | +2.0% |
Q2 2020 | $59,401,000 | +96.3% | 940,925 | +58.9% | 0.10% | +56.9% |
Q1 2020 | $30,262,000 | -35.5% | 592,313 | +0.3% | 0.06% | -21.7% |
Q4 2019 | $46,929,000 | -10.4% | 590,370 | -45.3% | 0.08% | +50.9% |
Q3 2019 | $52,354,000 | +126.8% | 1,079,020 | +145.9% | 0.06% | +10.0% |
Q2 2019 | $23,084,000 | -7.3% | 438,857 | -6.7% | 0.05% | -9.1% |
Q1 2019 | $24,897,000 | +30.1% | 470,385 | +0.9% | 0.06% | +14.6% |
Q4 2018 | $19,132,000 | +6.0% | 466,059 | -1.9% | 0.05% | +26.3% |
Q3 2018 | $18,044,000 | -4.3% | 474,848 | +13.9% | 0.04% | -15.6% |
Q2 2018 | $18,852,000 | +24.4% | 417,073 | +32.9% | 0.04% | +21.6% |
Q1 2018 | $15,153,000 | – | 313,720 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
Grace Capital | 124,749 | $6,878,000 | 5.33% |
Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |